| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.44 | 0.1 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.35 | 0.3 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.25 | 0.1 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.18 | 6e-05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.17 | 0.005 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.17 | 0.3 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.15 | 0.02 |